https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
001). In a case by case analysis Vliver10Gy was smaller than Vliver20Gy in 38/46 cases (83%). Dmean of the liver was significantly smaller in BT compared to SBRT (p .001). GTV volume was correlated to the liver exposure and showed an advantage of HDR BT over SBRT in comparison of clinically relevant doses, and for EQD2 equivalent doses. The advantage was more pronounced for greater liver lesions The Conformity Index (CI) was significantly better for BT, while Healthy Tissue Conformity Index (HTCI) and Conformation